Effect of aspirin on the carcinogenesis in patients with IPMN

Effect of aspirin on the carcinogenesis in patients with IPMN - Effect of aspirin on the carcinogenesis in patients with IPMN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034275

Enrollment

800

Registered

2018-09-26

Start date

2018-04-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IPMN

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: IPMN

Exclusion criteria

Exclusion criteria: 1. Previous pancreatic resection 2. Pancreatic cancer at the diagnosis 3. Follow up period of less than 6 months. 4. Insufficient data 5. Inappropriate case

Design outcomes

Primary

Measure	Time frame
Incidence of pancreatic cancer	—

Countries

Japan

Contacts

Public ContactKazumichi Kawakubo

Hokkaido University Department of Gastroenterology and Hepatology

kkawakubo-gi@umin.ac.jp0117161161

Outcome results